Implementation of a Very Low Calorie Diet for Remission of Type 2 Diabetes in the Community
1 other identifier
interventional
100
1 country
4
Brief Summary
The complications associated with uncontrolled type-2 diabetes mellitus (T2DM) are numerous; reducing the quality of life for the patient and consuming a considerable portion of healthcare finances. The Health of the Nation (HotN) 2011 study reported that 50% of the Barbadian population \>65years old had a diagnosis of T2DM and that two-thirds of the population were overweight - which is a risk factor for the development of T2DM. Encouraged by the success of the Counterpoint study in the United Kingdom (UK), the Barbados Diabetes Reversal Study 1 (BDRS1) was established using a similar protocol; the aim of which was to evaluate the feasibility of implementing a very low calorie diet to reverse T2DM in Barbados. At the end of the 8-week intervention period, the 25 participants had achieved an average weight loss of 10.1kg (22lbs). This was accompanied by an increase in the number of participants whose fasting blood sugars were now within normal range despite being off of their diabetes medication; and a decrease in the number of participants taking blood pressure medication. Participants transitioned to a solid diet over a 4-week period, with guidance on health dietary habits and regular exercise routines. The benefits accrued during the intervention phase were preserved at the end of the transition period. We now propose the Barbados Diabetes Remission Study 2 (BDRS2) as a sustainable community intervention - utilizing the local church as the community site. We hypothesize that this will enhance reach while reducing the cost of the study and will also facilitate the structures necessary for the social support of the participant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2019
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2018
CompletedFirst Posted
Study publicly available on registry
May 24, 2018
CompletedStudy Start
First participant enrolled
February 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedMarch 28, 2019
May 1, 2018
1.5 years
May 14, 2018
March 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
change in weight
enrolment, 12 weeks, 6 mths and 1 year
change in fasting glucose
Enrolment, 12 weeks, 6 months, 1 year
change in Hba1C
Enrolment, 12 weeks, 6 months, 1 year
Secondary Outcomes (3)
change in waist circumference
Enrolment, 12 weeks, 6 months, 1 year
change in blood pressure
Enrolment, 12 weeks, 6 months, 1 year
change in blood pressure medication
weekly for the first 12 weeks
Study Arms (1)
very low calorie liquid diet
EXPERIMENTALPhase 1: Caloric restriction Phase 2: Solid diet Phase 3: Transition to independence
Interventions
Phase 1: very low calorie liquid formulation Phase 2: Nutritionally balanced solid diet Phase 3: Educational material
Eligibility Criteria
You may qualify if:
- Adults aged 20 - 70 years old, all ethnicities
- Diagnosis of T2DM for \<6 years as defined by the American Diabetes Association
- Diagnosis of pre-diabetes as defined by the American Diabetes Association
- Body Mass index (BMI) of 27 kg/m2 and over
You may not qualify if:
- Insulin use
- Substance abuse
- Current cancer diagnosis
- myocardial infarction within last 6 month
- learning difficulties
- current treatment with anti-obesity drugs
- diagnosed eating disorder or purging
- HbA1c \> 10%
- pregnant/considering pregnancy
- evidence of liver disease (including liver enzymes \> 3 times above normal values)
- evidence of renal disease (creatinine of \> 150 mmol/l)
- persons who have required hospitalisation for depression, or are on antipsychotic drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Abundant Life Assembly
Bridgetown, Bank Hall, Saint Michael, Barbados
Ellerton Wesleyan Church
Bridgetown, Ellerton, Saint George, Barbados
River Road New Testament Church of God
Bridgetown, River Road, Saint Michael, Barbados
Mount of Praise Wesleyan Church
Bridgetown, Tudor Bridge, Saint Michael, Barbados
Related Publications (6)
Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011 Oct;54(10):2506-14. doi: 10.1007/s00125-011-2204-7. Epub 2011 Jun 9.
PMID: 21656330BACKGROUNDLean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Stefanetti R, Trenell M, Welsh P, Kean S, Ford I, McConnachie A, Sattar N, Taylor R. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018 Feb 10;391(10120):541-551. doi: 10.1016/S0140-6736(17)33102-1. Epub 2017 Dec 5.
PMID: 29221645BACKGROUNDUnwin N, Rose AMC, George KS, Hambleton IR, Howitt C. The Barbados Health of the Nation Survey: Core Findings. Chronic Disease Research Centre, The University of the West Indies and the Barbados Ministry of Health: St Michael, Barbados, January 2015; 48 pp
BACKGROUNDKaren Bynoe, Maddy Murphy, Charles Taylor, Andre Greenidge, Melissa Abed, Nigel Unwin. The Barbados Diabetes Reversal Study Preliminary Results https://www.cavehill.uwi.edu/fms/resources/cme/78th-cme-presentations/karen-bynoe-barbados-diabetes-reversal-study.aspx
BACKGROUNDQuimby KR, Murphy MM, Harewood H, Howitt C, Hambleton I, Jeyaseelan SM, Greaves N, Sobers N. Adaptation of a community-based type-2 diabetes mellitus remission intervention during COVID-19: empowering persons living with diabetes to take control. Implement Sci Commun. 2022 Jan 24;3(1):5. doi: 10.1186/s43058-022-00255-9.
PMID: 35074020DERIVEDQuimby KR, Sobers N, George C, Greaves N, Browman-Jones F, Samuels TA. Implementation of a community-based low-calorie dietary intervention for the induction of type-2 diabetes and pre-diabetes remission: a feasibility study utilising a type 2 hybrid design. Implement Sci Commun. 2021 Aug 28;2(1):95. doi: 10.1186/s43058-021-00196-9.
PMID: 34454636DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
T Alafia Samuels, MBBS, PhD
George Alleyne Chronic Disease Research Centre, The University of the West Indies
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2018
First Posted
May 24, 2018
Study Start
February 11, 2019
Primary Completion
August 1, 2020
Study Completion
December 1, 2020
Last Updated
March 28, 2019
Record last verified: 2018-05